Clinical Trials in Glendale, Arizona

Find clinical trials in Glendale, Arizona. Discover local research opportunities and treatment options in your area.

51 Active Trials Found in Glendale

Showing 51 trials on this page

Page 3 of 3

Zimberelimab and Domvanalimab in Combination With Chemotherapy Versus Pembrolizumab With Chemotherapy in Patients With Untreated Metastatic Non-Small Cell Lung Cancer

NCT ID: NCT05502237

This clinical trial is studying a new combination of treatments for patients with untreated metastatic non-small cell lung cancer (NSCLC), which is a type of lung cancer that has spread to other pa...

Recruiting

Phase: PHASE3 Conditions: Non-small Cell Lung Cancer

Combination Therapies With Adagrasib in Patients With Advanced NSCLC With KRAS G12C Mutation

NCT ID: NCT05609578

This clinical trial, called CA239-0010, is exploring a new treatment approach for patients with advanced non-small cell lung cancer (NSCLC) who have a specific genetic mutation known as KRAS G12C. ...

Recruiting

Phase: PHASE2 Conditions: Metastatic Lung Cancer, Advanced NSCLC

Effect of Naltrexone Hydrochloride ER and Bupropion Hydrochloride ER Combination (Contrave®/Mysimba®) on Major Adverse Cardiovascular Events (MACE)

NCT ID: NCT06098079

This clinical trial is studying the effects of a medication combination called naltrexone and bupropion (marketed as Contrave® or Mysimba®) on heart-related events in people with obesity. The goal ...

Recruiting

Phase: PHASE4 Conditions: Obesity

Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)

NCT ID: NCT05633654

The ASCENT-05 clinical trial is studying a new treatment approach for patients with triple negative breast cancer (TNBC) who still have cancer remaining after surgery and previous therapy. This tri...

Recruiting

Phase: PHASE3 Conditions: Triple Negative Breast Cancer

PerQdisc Traditional Feasibility Trial.

NCT ID: NCT06860867

The PerQdisc Traditional Feasibility Trial is a study aimed at exploring the safety and effectiveness of a new treatment for patients suffering from discogenic low back pain, which is pain caused b...

Recruiting

Phase: NA Conditions: Discogenic Low Back Pain

A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]

NCT ID: NCT05895786

**Clinical Trial Summary: Understanding PF-06823859 for Myositis** This clinical trial is studying a new medicine called PF-06823859 to see how well it works for people with active dermatomyositis...

Recruiting

Phase: PHASE3 Conditions: Myositis

EXpanding Prenatal Cell Free DNA Screening Across MoNogenic Disorders (EXPAND)

NCT ID: NCT06808880

The EXPAND trial is studying a new type of blood test called a single gene Non-Invasive Prenatal Test (sgNIPT). This test aims to help determine if a baby might be at risk for certain serious genet...

Recruiting

Conditions: Single Gene NIPT

A Study to Learn About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus Erythematosus

NCT ID: NCT04961567

This clinical trial is studying a new injection called litifilimab (also known as BIIB059) to see if it can help improve symptoms for adults with systemic lupus erythematosus (SLE), a chronic illne...

Recruiting

Phase: PHASE3 Conditions: Lupus Erythematosus, Systemic

Study of Vudalimab or Pembrolizumab in Combination With Chemotherapy as First-line Treatment in Patients With Advanced NSCLC

NCT ID: NCT06173505

This clinical trial is studying a new treatment approach for patients with advanced nonsquamous non-small cell lung cancer (NSCLC). The researchers want to find out the best dose of a drug called v...

Recruiting

Phase: PHASE1 Conditions: Nonsquamous Non-small Cell Lung Cancer

Study to Evaluate the Efficacy, Immunogenicity, and Safety of RSVpreF in Adults.

NCT ID: NCT05035212

This clinical trial is studying a vaccine called RSVpreF to see how well it works, how safe it is, and how it helps the immune system protect against respiratory illnesses caused by the respiratory...

Recruiting

Phase: PHASE3 Conditions: Lower Respiratory Tract Illness

A Phase 3 Study to Evaluate Safety and Biomarkers of Resmetirom (MGL-3196) in Patients With Non-alcoholic Fatty Liver Disease (NAFLD), MAESTRO-NAFLD-Open-Label-Extension (MAESTRO-NAFLD-OLE)

NCT ID: NCT04951219

The MAESTRO-NAFLD-OLE clinical trial is studying a medication called Resmetirom (MGL-3196) to see how safe and effective it is for people with Non-Alcoholic Fatty Liver Disease (NAFLD). This trial ...

Recruiting

Phase: PHASE3 Conditions: Non-Alcoholic Fatty Liver Disease

Search All Trials Browse All Locations